Complete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report.

Authors:
Atsuto Katano
Atsuto Katano
University of Tokyo Hospital
Bunky┼Ź | Japan
Hideomi Yamashita
Hideomi Yamashita
University of Tokyo Hospital
Japan
Kae Okuma
Kae Okuma
University of Tokyo Hospital
Japan
Keiichi Nakagawa
Keiichi Nakagawa
University of Tokyo Hospital
Japan

Oncol Lett 2016 Jun 19;11(6):3901-3903. Epub 2016 Apr 19.

Department of Radiation Oncology, University of Tokyo Hospital, Tokyo 113-8655, Japan.

Esophageal cancer is a highly lethal malignancy of the upper gastrointestinal tract. The recurrence of the cancer indicates a poor prognosis, and even salvage therapy using multi-agent combination chemotherapy, which is considered more effective than single-agent chemotherapy, is not able to achieve a sufficient response. The present study reports the case of a 74-year-old male who presented to a local hospital with dysphagia in February 2006. Upon radiographic and pathological examination, the patient was diagnosed with squamous cell carcinoma of esophagus that was clinically staged as T3N1M1. The patient was referred to the University of Tokyo Hospital (Tokyo, Japan) for concurrent chemoradiotherapy using a radiation dose of 50.4 Gy in 28 fractions, and subsequently achieved a complete response (CR). At 8 years after the initial diagnosis and subsequent treatment, the patient presented with abdominal swollen lymph nodes that were 38 mm and 22 mm in diameter. Recurrent metastasis was diagnosed. A single-agent regimen was selected due to the patient's poor performance status. This consisted of 2 cycles of oral S-1 administration twice a day for 2 consecutive weeks, followed by 2 weeks of rest (80 mg/day for 14 days/cycle). A CR was achieved following the use of S-1 administration as salvage therapy. The patient exhibited no signs of recurrence subsequent to 9 months of follow-up. Overall, the present study reports that S-1 administration shows marked effectiveness in the treatment of huge recurrent lesions. S-1 is considered as a good treatment option in patients with poor a performance status who require salvage therapy.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888222PMC
June 2016
7 Reads

Publication Analysis

Top Keywords

s-1 administration
12
salvage therapy
12
performance status
8
esophageal cancer
8
poor performance
8
study reports
8
complete response
8
patient
5
s-1
5
diagnosis subsequent
4
subsequent treatment
4
subsequently achieved
4
initial diagnosis
4
fractions subsequently
4
years initial
4
achieved complete
4
response years
4
patient presented
4
nodes diameter
4
diameter recurrent
4

Similar Publications

Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.

J Adv Pract Oncol 2012 May;3(3):161-9

The University of Texas MD Anderson Cancer Center, Houston, Texas.

Case Study Ms. S.G. Read More

View Article
May 2012

[A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].

Gan To Kagaku Ryoho 2011 Nov;38(12):2397-400

Division of Digestive Surgery, Dept. of Surgery, Kyoto Prefectural University of Medicine.

Patients with T4 esophageal cancer generally have poor prognosis. Of these patients, prognosis of non-responder to chemoradiothrapy (CRT) is extremely poor. We report a case of residual lymph node metastasis following definitive CRT, which showed a good response to outpatient clinic-based chemotherapy consisting of docetaxel (DOC) followed by S-1 in a patient with T4 esophageal cancer. Read More

View Article
November 2011

Stereotactic body radiotherapy for oligo-recurrence in the liver in a patient with esophageal carcinoma: A case report.

Mol Clin Oncol 2017 Dec 4;7(6):1061-1063. Epub 2017 Oct 4.

Department of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for solitary cancerous lesions. The present study reported a rare case of sustained remission after SBRT for oligorecurrence in the liver in a patient with esophageal carcinoma. A 60-year-old Japanese man presented with a chief complaint of dysphagia. Read More

View Article
December 2017

Re-irradiation of locoregional esophageal cancer recurrence following definitive chemoradiotherapy: A report of 6 cases.

Mol Clin Oncol 2017 Oct 18;7(4):681-686. Epub 2017 Aug 18.

Department of Radiology, University of Tokyo Hospital, Tokyo 113-8655, Japan.

There is currently no consensus on salvage therapy for recurrent esophageal cancer. Salvage surgery is a well-established option for attaining long-term survival; however, it is associated with a high risk of perioperative morbidity and mortality. A total of 6 patients who underwent re-irradiation for recurrence of locoregional esophageal cancer following definitive chemoradiotherapy were investigated. Read More

View Article
October 2017